TSX · BLCO.TO
Bausch + Lomb Corporation
CA$28.10-CA$0.65 (-2.26%)
Bausch + Lomb Corporation’s quoted price sits in the upper half of its reported 52-week range, 5.48% below the high.
Loading market information…
CNQ · CANN.CN · CAD
Stock price, earnings
Quote as of Jul 23, 2024, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · CAD. Historical prices are not a forecast.
Heritage Cannabis Holdings Corp.’s quoted price sits in the lower half of its reported 52-week range, 75.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Heritage Cannabis Holdings Corp.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Headquartered in Toronto, Canada, Heritage Cannabis Holdings Corp. was established in 2007 and functions as a cannabinoid company operating across both Canada and the United States. Through its various subsidiaries, the firm specializes in the extraction of cannabis and the subsequent development of a wide array of derived products and distinct brands. These offerings serve both the adult recreational market and various cannabis-based medical applications. The company's diverse brand portfolio includes Purefarma, which supplies medicinal-grade cannabis formulations to pharmaceutical, recreational, and cosmeceutical industries. For concentrates, it offers Pura Vida (featuring CBD, indica, sativa, and hybrid varieties), Premium 5 (focused on tetrahydrocannabinol concentrates), and RAD (for general concentrates). Furthermore, Heritage provides skincare and wellness items under the feelgood. brand, hemp-based formulations via ArthroCBD, and medical delivery formats such as oral capsules, sublingual filmstrips, and topical gels and creams through its CB4 line. The entity operated as Umbral Energy Corp. until its name was officially changed to Heritage Cannabis Holdings Corp. in January 2018.
Latest available per-share figures in CAD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:20 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CA$28.10-CA$0.65 (-2.26%)
Bausch + Lomb Corporation’s quoted price sits in the upper half of its reported 52-week range, 5.48% below the high.
CA$33.53-CA$0.14 (-0.42%)
Apotex Health Corp.’s quoted price sits in the upper half of its reported 52-week range, 16.79% below the high.
CA$0.04+CA$0.01 (+16.67%)
Willow Biosciences Inc.’s quoted price sits in the lower half of its reported 52-week range, 95.17% below the high.
CA$0.04+CA$0.01 (+33.33%)
The BC Bud Corporation’s quoted price sits in the lower half of its reported 52-week range, 74.19% below the high.
CA$0.01+CA$0.01 (+100.0%)
Luff Enterprises Ltd.: Healthcare · Drug Manufacturers - Specialty & Generic.
CA$0.01-CA$0.01 (-33.33%)
Filament Health Corp.’s quoted price sits in the lower half of its reported 52-week range, 85.71% below the high.
CA$0.04CA$0.00 (0.0%)
Empower Clinics Inc.’s quoted price sits in the lower half of its reported 52-week range, 11.11% below the high.
$0.00$0.00 (0.0%)
StageZero Life Sciences Ltd.’s quoted price sits in the lower half of its reported 52-week range, 91.45% below the high.
